News

Thumbnail

“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11. 

UnitedHealthcare UHC UnitedHealth

Meanwhile, the Maryland State Medical Society is formally urging the administration to reject the mid-year request, contending it will harm patients and providers. 

money brain artificial intelligence dollars

John S. Scales, MD, a vascular and interventional specialist with Radiology Associates of Ocala in central Florida, has agreed to the terms, according to the state. 

heart doctors and surgeons working together. top cardiology hospitals in the United States.

The program was based on preferences the organization’s staff radiologists had expressed interest in previously. 

angel devil temptation

Researchers warn of potential perdition—so to speak—for doing algorithmic medicine wrong in any of these easily avoidable ways. 

Elizabeth Warren

The Patients Before Monopolies Act was introduced into both the U.S. Senate and House of Representatives with bipartisan support. If it passes, pharmacy benefit managers would be required to divest from retail stores.

AI helps spot pancreatic cancer over a year before radiologists can

Researchers are optimistic about the treatment's potential, as more options for pancreatic cancer are "urgently needed."

Thumbnail

Good Samaritan Regional Medical Center is named in a court filing against a physician at the facility who allegedly failed to clean a wound, leaving 12 pieces of twigs, moss and pine needles inside. The alleged victim, an 18-year-old man, later died.

heart drugs with stethoscope

Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.

Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA

Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.

chest pain lung pulmonary embolism

In new Neiman Health Policy Institute research, scientists explored the use of artificial intelligence to aid in diagnosing PE on CTPA, with “AI-informed radiologists" scoring high marks. 

Around the web

“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11. 

Meanwhile, the Maryland State Medical Society is formally urging the administration to reject the mid-year request, contending it will harm patients and providers. 

John S. Scales, MD, a vascular and interventional specialist with Radiology Associates of Ocala in central Florida, has agreed to the terms, according to the state.